Company Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab.
The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies.
The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables.
The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services.
The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.
Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
| Country | United States |
| Founded | 1999 |
| IPO Date | Nov 18, 1999 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 17,900 |
| CEO | Padraig McDonnell |
Contact Details
Address: 5301 Stevens Creek Boulevard Santa Clara, California 95051 United States | |
| Phone | 800 227 9770 |
| Website | agilent.com |
Stock Details
| Ticker Symbol | A |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | November - October |
| Reporting Currency | USD |
| CIK Code | 0001090872 |
| CUSIP Number | 00846U101 |
| ISIN Number | US00846U1016 |
| Employer ID | 77-0518772 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Padraig McDonnell | Chief Executive Officer, President and Director |
| Robert W. McMahon C.M.A. | Senior Vice President and Chief Financial Officer |
| Henrik Ancher-Jensen | Senior Vice President and President of Order Fulfillment and Supply Chain |
| Dr. Simon May | SVice President and President of LDG |
| Rodney Gonsalves | Principal Accounting Officer, Vice President and Corporate Controller |
| Parmeet Ahuja | Vice President of Investor Relations |
| Bret M. DiMarco | Senior Vice President, Chief Legal Officer, and Secretary |
| Frederick Schwarz | SVice President, Chief Strategy and Corporate Development Officer |
| Chris Swenson | Vice President and Interim Chief Human Resources Officer |
| Yvonne Mackie | MD of UK and Ireland Operations and Vice President of Human Resources - Europe |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 17, 2025 | 8-K | Current Report |
| Mar 17, 2025 | 144 | Filing |
| Mar 6, 2025 | 144 | Filing |
| Mar 3, 2025 | 8-K | Current Report |
| Mar 3, 2025 | 10-Q | Quarterly Report |
| Feb 26, 2025 | 8-K | Current Report |
| Feb 21, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Feb 13, 2025 | SCHEDULE 13G/A | Filing |
| Jan 31, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jan 31, 2025 | ARS | Filing |